Prevalence of unprotected anal intercourse among HIV-diagnosed MSM in the United States: a meta-analysis

被引:189
作者
Crepaz, Nicole [1 ]
Marks, Gary [1 ]
Liau, Adrian [1 ]
Mullins, Mary M. [1 ]
Aupont, Latrina W. [1 ]
Marshall, Khiya J. [1 ]
Jacobs, Elizabeth D. [1 ]
Wolitski, Richard J. [1 ]
机构
[1] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Prevent Res Branch, Atlanta, GA 30333 USA
关键词
HIV/AIDS; men who have sex with men; people living with HIV; serosorting; strategic positioning; unprotected sex; SEXUAL RISK BEHAVIOR; ACTIVE ANTIRETROVIRAL THERAPY; TRANSMISSION RISK; BISEXUAL MEN; POSITIVE MEN; PREVENTION STRATEGIES; SEROPOSITIVE MEN; HARM REDUCTION; INFECTED MEN; VIRAL LOAD;
D O I
10.1097/QAD.0b013e32832effae
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
Objective: To integrate the empirical findings on the prevalence of unprotected anal intercourse (UAI) among HIV-diagnosed men who have sex with men (MSM) in the United States. Methods: Comprehensively searching MEDLINE, EMBASE, PsycINFO (2000-2007), hand searching bibliographic lists, and contacting researchers. Thirty US studies (n = 18 121) met selection criteria. Analyses were conducted using random-effects models and meta-regress ion. Results: The prevalence of UAI was considerably higher with HIV-seropositive partners (30%; 95% confidence interval 25-36) than with serostatus unknown (16%; 95% confidence interval 13-21) or HIV-seronegative partners (13%; 95% confidence interval 10-16). The prevalence of UAI with either a serostatus unknown or HIV-seronegative partner was 26%. The UAI prevalence did not differ by the length of the behavioral recall window but did vary by the type of anal intercourse (insertive vs. receptive). Studies with the following features had a lower UAI prevalence: recruiting participants before 2000, MSM of color being the majority of study sample, recruiting participants from medical settings, using random or systematic sampling methods, and having interviewers administer the questionnaire. Being on antiretroviral therapy, having an undetectable viral load, and reporting more than 90% medication adherence were not associated with UAI. Conclusion: Most HIV-diagnosed MSM protect partners during sexual activity, but a sizeable percentage continues to engage in sexual behaviors that place others at risk for HIV infection and place themselves at risk for other sexually transmitted infections. Prevention with positives programs continues to be urgently needed for MSM in the United States. (C) 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins
引用
收藏
页码:1617 / 1629
页数:13
相关论文
共 69 条
[1]
HIV-positive men sexually active with women: Sexual behaviors and sexual risks [J].
Aidala, Angela A. ;
Lee, Gunjeong ;
Howard, Joyce Moon ;
Caban, Maria ;
Abramson, David ;
Messeri, Peter .
JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE, 2006, 83 (04) :637-655
[2]
Sifakis F., 2005, Morbidity and Mortality Weekly Report, V54, P597
[3]
[Anonymous], 2004, MMWR, V53, P891
[4]
[Anonymous], 2009, HIV/AIDS Surveillance Report, 2007, P19
[5]
Bingman C.R., 2001, AIDS BEHAV, V5, P283, DOI DOI 10.1023/A:1011348828325
[6]
Human immunodeficiency virus superinfection and recombination: Current state of knowledge and potential clinical consequences [J].
Blackard, JT ;
Cohen, DE ;
Mayer, KH .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (08) :1108-1114
[7]
The probable source of both the primary multidrug-resistant (MDR) HIV-1 strain found in a patient with rapid progression to AIDS and a second recombinant MDR strain found in a chronically HIV-1-infected patient [J].
Blick, Gary ;
Kagan, Ron M. ;
Coakley, Eoin ;
Petropoulos, Christos ;
Maroldo, Laura ;
Greiger-Zanlungo, Paola ;
Gretz, Scott ;
Garton, Trish .
JOURNAL OF INFECTIOUS DISEASES, 2007, 195 (09) :1250-1259
[8]
Borenstein M., 2013, BIOSTAT
[9]
Association between crack cocaine use and high-risk sexual behaviors after HIV diagnosis [J].
Campsmith, ML ;
Nakashima, AK ;
Jones, JL .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 25 (02) :192-198
[10]
Centers for Disease Control and Prevention (CDC), 2003, MMWR Recomm Rep, V52, P1